Aber auch falsche Ernhrung und Bewegungsmangel knnen den Glutathionspiegel senken
If you took a popular GLP-1 drug and now suffer from severe gastrointestinal issues, you are not alone
The abstract (but not the complete study) for the SURMOUNT-OSA trial was just published in the New England Journal of Medicine
It contains salicylate, which is chemically related to aspirin
The cardiovascular protection offered by GLP-1 receptor agonists stems from several complementary mechanisms: Anti-inflammatory effects through suppression of CRP, TNF-, and other inflammatory markers Substantial weight reduction, particularly with higher doses of newer agents Blood pressure modulation via direct vascular effects and enhanced natriuresis Improved endothelial function and lipid profiles Renal protective effects, including reduced albuminuria and slowed eGFR decline Though initially established in type 2 diabetes populations, recent evidence from the SELECT trial confirms these benefits extend to non-diabetic patients with obesity and established cardiovascular disease
Its particularly beneficial for adults with obesity or those who are overweight with associated health conditions